Safety and immunogenicity of booster vaccination and fractional dosing with Ad26.COV2.S or BNT162b2 in Ad26.COV2.S-vaccinated participants.
在接种过 Ad26.COV2.S 疫苗的受试者中，加强免疫接种和分次接种 Ad26.COV2.S 或 BNT162b2 的安全性和免疫原性
期刊:PLOS Global Public Health
影响因子:2.5
doi:10.1371/journal.pgph.0002703
Riou Catherine, Bhiman Jinal N, Ganga Yashica, Sawry Shobna, Ayres Frances, Baguma Richard, Balla Sashkia R, Benede Ntombi, Bernstein Mallory, Besethi Asiphe S, Cele Sandile, Crowther Carol, Dhar Mrinmayee, Geyer Sohair, Gill Katherine, Grifoni Alba, Hermanus Tandile, Kaldine Haajira, Keeton Roanne S, Kgagudi Prudence, Khan Khadija, Lazarus Erica, Le Roux Jean, Lustig Gila, Madzivhandila Mashudu, Magugu Siyabulela F J, Makhado Zanele, Manamela Nelia P, Mkhize Qiniso, Mosala Paballo, Motlou Thopisang P, Mutavhatsindi Hygon, Mzindle Nonkululeko B, Nana Anusha, Nesamari Rofhiwa, Ngomti Amkele, Nkayi Anathi A, Nkosi Thandeka P, Omondi Millicent A, Panchia Ravindre, Patel Faeezah, Sette Alessandro, Singh Upasna, van Graan Strauss, Venter Elizabeth M, Walters Avril, Moyo-Gwete Thandeka, Richardson Simone I, Garrett Nigel, Rees Helen, Bekker Linda-Gail, Gray Glenda, Burgers Wendy A, Sigal Alex, Moore Penny L, Fairlie Lee
